IFNA1 and Other metabolic disease: Likewise, recent studies have indicated that the insulin/IGF axis may have a role in metabolic disorders, namely during the de-activation of aberrant IFN stimulation, contributing to the development of a successful strategy to prevent harmful IFN signaling [80].